Previous close | 274.67 |
Open | 275.00 |
Bid | 275.23 x 100 |
Ask | 276.81 x 100 |
Day's range | 273.83 - 279.98 |
52-week range | 204.44 - 279.98 |
Volume | |
Avg. volume | 527,067 |
Market cap | 12.261B |
Beta (5Y monthly) | 0.54 |
PE ratio (TTM) | 13.08 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
On May 15, 2024, James Edgemond, the Chief Financial Officer and Treasurer of United Therapeutics Corp (NASDAQ:UTHR), sold 40,160 shares of the company.
On May 15, 2024, Director Christopher Causey sold 2,000 shares of United Therapeutics Corp (NASDAQ:UTHR) as reported in a recent SEC Filing.